-+ 0.00%
-+ 0.00%
-+ 0.00%

Truist Securities Reiterates Buy on BioNTech, Raises Price Target to $155

Benzinga·06/03/2025 14:22:19
Listen to the news
Truist Securities analyst Asthika Goonewardene reiterates BioNTech (NASDAQ:BNTX) with a Buy and raises the price target from $151 to $155.